Medtronic (NYSE:MDT) announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI).

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) clearance for its new InPen app, which features missed meal dose detection. This latest FDA clearance should pave the way for ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

The FDA is currently reviewing the compatibility of the Simplera sensor with the MiniMed Go system.

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...

Missed insulin doses cause complications. A new Medtronic app can detect when patients forget a dose. The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin delivery system, according to an industry press release.

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. With this clearance, the ...